Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vaidya

Showing results (381-390 of 390) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 390 results.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2018
Mobility shift of beta-dystroglycan as a marker of <i>GMPPB</i> gene-related muscular dystrophyAnna Sarkozy, Silvia Torelli, Rachael Mein, et al.
Communications Biology|August 24, 2022
Egg-laying and locomotory screens with C. elegans yield a nematode-selective small molecule stimulator of neurotransmitter releaseSean Harrington, Jessica J Knox, Andrew R Burns, et al.
Nature|May 24, 2023
Selective control of parasitic nematodes using bioactivated nematicidesAndrew R Burns, Rachel J Baker, Megan Kitner, et al.
Nature Communications|March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humansKodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
BMJ (Clinical Research Ed.)|August 21, 2020
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trialJayant S Vaidya, Max Bulsara, Michael Baum, et al.
The Journal of Biological Chemistry|May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionalityD Lee, S A Long, J L Adams, et al.
JAMA Oncology|April 3, 2020
Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast CancerJayant S Vaidya, Max Bulsara, Christobel Saunders, et al.
Science Translational Medicine|March 20, 2015
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapyJoel D Leverson, Darren C Phillips, Michael J Mitten, et al.
British Journal of Cancer|May 26, 2021
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancerJayant S Vaidya, Max Bulsara, Michael Baum, et al.
Science Advances|October 4, 2024
BCL-X<sub>L</sub>-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitorsAndrew S Judd, Bhupinder Bawa, Wayne R Buck, et al.
Pageof 39

Showing results (381-390 of 390) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 390 results.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2018
Mobility shift of beta-dystroglycan as a marker of <i>GMPPB</i> gene-related muscular dystrophyAnna Sarkozy, Silvia Torelli, Rachael Mein, et al.
Communications Biology|August 24, 2022
Egg-laying and locomotory screens with C. elegans yield a nematode-selective small molecule stimulator of neurotransmitter releaseSean Harrington, Jessica J Knox, Andrew R Burns, et al.
Nature|May 24, 2023
Selective control of parasitic nematodes using bioactivated nematicidesAndrew R Burns, Rachel J Baker, Megan Kitner, et al.
Nature Communications|March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humansKodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
BMJ (Clinical Research Ed.)|August 21, 2020
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trialJayant S Vaidya, Max Bulsara, Michael Baum, et al.
The Journal of Biological Chemistry|May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionalityD Lee, S A Long, J L Adams, et al.
JAMA Oncology|April 3, 2020
Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast CancerJayant S Vaidya, Max Bulsara, Christobel Saunders, et al.
Science Translational Medicine|March 20, 2015
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapyJoel D Leverson, Darren C Phillips, Michael J Mitten, et al.
British Journal of Cancer|May 26, 2021
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancerJayant S Vaidya, Max Bulsara, Michael Baum, et al.
Science Advances|October 4, 2024
BCL-X<sub>L</sub>-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitorsAndrew S Judd, Bhupinder Bawa, Wayne R Buck, et al.
Pageof 39